Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Virpax Pharmaceuticals Q2 EPS $(0.47) Down From $(0.41) YoY

Virpax Pharmaceuticals (NASDAQ:VRPX) reported quarterly losses of $(0.47) per share. This is a 14.63 percent decrease over losses of $(0.41) per share from the same period last year.
byBill Haddad
August 10, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Virpax Pharmaceuticals (NASDAQ:VRPX) reported quarterly losses of $(0.47) per share. This is a 14.63 percent decrease over losses of $(0.41) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts